India Glycols: NCLT Reserves Order on Scheme of Arrangement
India Glycols Limited announced that the NCLT has reserved its order on the Scheme of Arrangement for demerger. The NCLT reserved the matter on July 2, 2026. The Income Tax Department raised an issue regarding a ₹27,890 demand.
The Scheme of Arrangement involves a demerger, which is a significant corporate restructuring. The NCLT's final order will determine the successful execution of this plan, thus having a medium-term impact on the company's structure and operations.
The announcement is a procedural update regarding a legal process. While the NCLT reserving its order is a step forward, the outcome is not yet known, and there's a minor dispute with the Income Tax Department, making the sentiment neutral.
India Glycols Limited (IGL) has informed the stock exchanges that the Hon’ble National Company Law Tribunal (NCLT), Allahabad Bench, has reserved its final order regarding the Scheme of Arrangement. This scheme involves the demerger of India Glycols Limited into Ennature Bio pharma Limited and IGL Spirits Limited.
The NCLT's decision was reserved on July 2nd, 2026, and the order was uploaded on July 3rd, 2026. This update follows a previous intimation on May 21st, 2026, concerning the Scheme.
The NCLT proceedings on July 2nd, 2026, addressed the Scheme of Demerger. While the meetings of secured creditors and resulting companies were dispensed with, a report from the Registrar of Companies (RoC) cum Official Liquidator (OL), Uttarakhand, indicated no adverse observations. A point of contention raised by the Income Tax Department concerned an outstanding demand of ₹27,890 raised on May 6th, 2026. The petitioner's counsel stated that the principal amount was deposited on July 6th, 2023, and argued that no interest should accrue. However, the Income Tax Department noted the discrepancy in payment dates. The petitioner's counsel undertook to be bound by any outstanding demand post-sanction of the Scheme, particularly for the demerging company, India Glycols Limited.
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under demerger. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.